LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
MenopauseBrain ActivityCognition
Interventions
DRUG

Lisdexamfetamine

The overall objective of this study is to assess the effects of LDX on brain activation patterns during tasks of sustained attention and working memory in menopausal women.

OTHER

Placebo

To assess the effects of a placebo pill on brain activation patterns during tasks of sustained attention and working memory in menopausal women.

Trial Locations (1)

19104

University of Pennsylvania, Penn Center for Womens Behavioral Wellness, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT01977625 - LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women | Biotech Hunter | Biotech Hunter